NASHUA, N.H., June 11 /PRNewswire-FirstCall/ -- iCAD, Inc. , an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced that Ken Ferry, Chief Executive Officer of iCAD, will be presenting at the Needham and Company 6th Annual Biotechnology and Medical Technology Conference on Thursday, June 14, 2007 at 3:00 p.m. (Eastern Daylight Time) at The New York Palace hotel in New York.
The presentation will be webcast live and archived for replay on the “Investors” section of the company’s Web site at http://www.icadmed.com.
An audio webcast of the presentation will be available after the conference at http://www.wsw.com/webcast/needham18/icad/.
About iCAD, Inc.
iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by over one thousand women’s healthcare centers worldwide. For more information, call +1 877 iCADnow or visit http://www.icadmed.com.
For iCAD, contact Darlene Deptula-Hicks, EVP and CFO at 603-882-5200 x7944 or via email at ddeptula@icadmed.com
For iCAD Investor Relations, contact Kevin McGrath of Cameron Associates at 212-245-4577 or via email at kevin@cameronassoc.com
For iCAD Public Relations, contact Wendy Ryan of Schwartz Communications at 781-684-0770 or via email at icad@schwartz-pr.com
iCAD, Inc.
CONTACT: Darlene Deptula-Hicks, EVP and CFO of iCAD, Inc.,+1-603-882-5200, Ext. 7944, ddeptula@icadmed.com; or Investor Relations,Kevin McGrath of Cameron Associates, +1-212-245-4577,kevin@cameronassoc.com, for iCAD, Inc.; or Public Relations, Wendy Ryan ofSchwartz Communications, +1-781-684-0770; icad@schwartz-pr.com, for iCAD,Inc.
